NASDAQ:SPNE - Nasdaq - US81255T1088 - Common Stock - Currency: USD
9.54
+0.73 (+8.29%)
The current stock price of SPNE is 9.54 USD. In the past month the price increased by 24.38%. In the past year, price decreased by -24.58%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
SYK | STRYKER CORP | 31.4 | 145.92B | ||
MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
DXCM | DEXCOM INC | 53.81 | 34.68B | ||
RMD | RESMED INC | 26.21 | 34.03B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
SeaSpine Holdings Corp. operates as a medical technology company. The company is headquartered in Carlsbad, California and currently employs 523 full-time employees. The company went IPO on 2015-06-17. The firm is focused on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The company offers a portfolio of orthobiologics and spinal implant solutions, as well as a surgical navigation system, to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures in the lumbar, thoracic, and cervical spine. Its orthobiologics products consist of a range of advanced and traditional bone graft substitutes designed to improve bone fusion rates following a range of orthopedic surgeries, including spine, hip, and extremities procedures. The firm's spinal implants and enabling technologies portfolio consists of a line of products and image-guided surgical solutions to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures.
SEASPINE HOLDINGS CORP
5770 Armada Dr
Carlsbad CALIFORNIA 92008 US
CEO: Keith C. Valentine
Employees: 523
Company Website: https://investor.seaspine.com/
Phone: 17607278399.0
The current stock price of SPNE is 9.54 USD. The price increased by 8.29% in the last trading session.
The exchange symbol of SEASPINE HOLDINGS CORP is SPNE and it is listed on the Nasdaq exchange.
SPNE stock is listed on the Nasdaq exchange.
14 analysts have analysed SPNE and the average price target is 16.13 USD. This implies a price increase of 69.06% is expected in the next year compared to the current price of 9.54. Check the SEASPINE HOLDINGS CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SEASPINE HOLDINGS CORP (SPNE) has a market capitalization of 354.91M USD. This makes SPNE a Small Cap stock.
SEASPINE HOLDINGS CORP (SPNE) currently has 523 employees.
SEASPINE HOLDINGS CORP (SPNE) has a support level at 7.37. Check the full technical report for a detailed analysis of SPNE support and resistance levels.
The Revenue of SEASPINE HOLDINGS CORP (SPNE) is expected to grow by 24.57% in the next year. Check the estimates tab for more information on the SPNE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SPNE does not pay a dividend.
SEASPINE HOLDINGS CORP (SPNE) will report earnings on 2023-03-09.
SEASPINE HOLDINGS CORP (SPNE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.77).
ChartMill assigns a technical rating of 8 / 10 to SPNE. When comparing the yearly performance of all stocks, SPNE is one of the better performing stocks in the market, outperforming 92.08% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to SPNE. The financial health of SPNE is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months SPNE reported a non-GAAP Earnings per Share(EPS) of -1.77. The EPS decreased by -20.41% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | 0.09 |
ChartMill assigns a Buy % Consensus number of 86% to SPNE. The Buy consensus is the average rating of analysts ratings from 14 analysts.
For the next year, analysts expect an EPS growth of -1.82% and a revenue growth 24.57% for SPNE